1. Academic Validation
  2. Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine

Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine

  • Gut. 2014 Jun;63(6):928-37. doi: 10.1136/gutjnl-2013-304901.
Kara Gross Margolis 1 Korey Stevanovic Zhishan Li Qi Melissa Yang Tamas Oravecz Brian Zambrowicz Kanchan G Jhaver Alexander Diacou Michael D Gershon
Affiliations

Affiliation

  • 1 Department of Pediatrics, Columbia University, College of P&S, , New York, New York, USA.
Abstract

Objective: Enterochromaffin cell-derived serotonin (5-HT) promotes intestinal inflammation. We tested hypotheses that peripheral Tryptophan Hydroxylase (TPH) inhibitors, administered orally, block 5-HT biosynthesis and deplete 5-HT from enterochromaffin cells sufficiently to ameliorate intestinal inflammation; moreover, peripheral TPH inhibitors fail to enter the murine enteric nervous system (ENS) or central nervous systems and thus do not affect constitutive gastrointestinal motility.

Design: Two peripheral TPH inhibitors, LP-920540 and telotristat etiprate (LX1032; LX1606) were given orally to mice. Effects were measured on 5-HT levels in the gut, blood and brain, 5-HT immunoreactivity in the ENS, gastrointestinal motility and severity of trinitrobenzene sulfonic acid (TNBS)-induced colitis. Quantitation of clinical scores, histological damage and intestinal expression of inflammation-associated cytokines and chemokines with focused microarrays and real-time Reverse Transcriptase PCR were employed to evaluate the severity of intestinal inflammation.

Results: LP-920540 and LX1032 reduced 5-HT significantly in the gut and blood but not in the brain. Neither LP-920540 nor LX1032 decreased 5-HT immunoreactive neurons or fibres in the myenteric plexus and neither altered total gastrointestinal transit time, colonic motility or gastric emptying in mice. In contrast, oral LP-920540 and LX1032 reduced the severity of TNBS-induced colitis; the expression of 24% of 84 genes encoding inflammation-related cytokines and chemokines was lowered at least fourfold and the reduced expression of 17% was statistically significant.

Conclusions: Observations suggest that that peripheral TPH inhibitors uncouple the positive linkage of enterochromaffin cell-derived 5-HT to intestinal inflammation. Because peripheral TPH inhibitors evidently do not enter the murine ENS, they lack deleterious effects on constitutive intestinal motility in mice.

Keywords

Enteric Nervous System; Experimental Colitis; Gastrointestinal Transit; Neurogastroenterology; Serotonin.

Figures
Products